(4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one

C33H39NO4Si — CID 12018409

IUPAC(4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one
SMILESC[C@H](C/C=C/C(=O)N1C(=O)OC[C@H]1Cc1ccccc1)CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C
InChIInChI=1S/C33H39NO4Si/c1-26(15-14-22-31(35)34-28(25-37-32(34)36)23-27-16-8-5-9-17-27)24-38-39(33(2,3)4,29-18-10-6-11-19-29)30-20-12-7-13-21-30/h5-14,16-22,26,28H,15,23-25H2,1-4H3/b22-14+/t26-,28-/m1/s1
InChIKeyBKAPHTCNYQDRJJ-NTHYDAKXSA-N
MW541.76 g/mol
LogP5.74
Rot. Bonds10

About (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one

(4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one (PubChem CID 12018409) has the molecular formula C33H39NO4Si and a molecular weight of 541.76 g/mol. Its IUPAC name is (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name(4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one
PubChem CID12018409
Molecular FormulaC33H39NO4Si
Molecular Weight541.76 g/mol
Exact Mass541.26
IUPAC Name(4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one
SMILESC[C@H](C/C=C/C(=O)N1C(=O)OC[C@H]1Cc1ccccc1)CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C
InChIInChI=1S/C33H39NO4Si/c1-26(15-14-22-31(35)34-28(25-37-32(34)36)23-27-16-8-5-9-17-27)24-38-39(33(2,3)4,29-18-10-6-11-19-29)30-20-12-7-13-21-30/h5-14,16-22,26,28H,15,23-25H2,1-4H3/b22-14+/t26-,28-/m1/s1
InChIKeyBKAPHTCNYQDRJJ-NTHYDAKXSA-N
XLogP5.74
TPSA55.84 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds10
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500541.76
LogP ≤ 55.74
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one?
The IUPAC name of (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one (CID 12018409) is (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one.
What is the SMILES notation for (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one?
The canonical SMILES for (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one is C[C@H](C/C=C/C(=O)N1C(=O)OC[C@H]1Cc1ccccc1)CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C.
What is the InChIKey of (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one?
The InChIKey is BKAPHTCNYQDRJJ-NTHYDAKXSA-N. The full InChI is InChI=1S/C33H39NO4Si/c1-26(15-14-22-31(35)34-28(25-37-32(34)36)23-27-16-8-5-9-17-27)24-38-39(33(2,3)4,29-18-10-6-11-19-29)30-20-12-7-13-21-30/h5-14,16-22,26,28H,15,23-25H2,1-4H3/b22-14+/t26-,28-/m1/s1.
What are the key properties of (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one?
(4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one has a molecular weight of 541.76 g/mol, XLogP of 5.74, 10 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-4-benzyl-3-[(E,5R)-6-[tert-butyl(diphenyl)silyl]oxy-5-methylhex-2-enoyl]-1,3-oxazolidin-2-one is sourced from PubChem (CID 12018409), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).